CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults over 60
June 21, 2023 at 17:57 PM EDT
The CDC panel's recommendation moves the U.S. closer to making the respiratory syncytial virus shots from Pfizer and GSK available to seniors.
